Octreotide LAR

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET

A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs

Real-world Study on Adjuvant Octreotide Therapy in pNETs

Acromegaly Combination Treatment Study

Tolvaptan-Octreotide LAR Combination in ADPKD

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours

Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber

Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET

Surgical Debulking of Pituitary Adenomas

Everolimus and LongActing Octreotide Trial in Polycystic Livers

Octreotide LAR as Maintenance Treatment for Patients With NEC

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis

Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients

Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly

Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis

Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients